Q BioMed Inc.
QBIO
|
$0.0002
100.0%
100.0%
1.1K
|
Professional, Scientific, and T...
(0.0% 1d) (-99.7% 1m) (-100.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (87.65% volume)
Earnings Calendar:
Market Cap: $ 29,019
Sec Filling | Patents | 6 employees
q biomed inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. the company offers strontium chloride sr89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies; and metastron, a radiopharmaceutical drug for metastatic cancer bone pain therapy. it is also developing man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; qbm-001 for rare pediatric non-verbal autism spectrum disorder; and uttroside-b for liver cancer. q biomed inc. has a partnership with mannin research for the development of novel covid-19 therapeutics. the company was formerly known as ismo tech solutions, inc. and changed its name to q biomed inc. in july 2015. q biomed inc. was founded in 2013 and is based in new york, new york.
covid
add to watch list Paper trade email alert is off
Press-releases
Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032, Predicts DelveInsight | Key Companies in the Market - SPARC, AbbVie, Ocuphire, Santen, Glaukos, Ocular Therapeutix, VivaVision Biotech, MediPrint Ophthalmics
Published: 2023-10-12 (Crawled : 21:00) - prnewswire.com
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: 0.0%
GKOS M | $95.13 -1.82% 0.0% 380K
|
Health Technology
|
| O: -0.41%
H: 0.51%
C: -0.21%
OCUL | News | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
|
| O: 0.4%
H: 1.18%
C: -1.97%
glaucoma companies ocular market
Autism Spectrum Disorder Therapeutics Market to Grow by USD 772.65 million from 2022 to 2027 | Increasing prevalence of ASD boosts the market growth - Technavio
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -27.59%
H: 0.0%
C: 0.0%
TVTX | $5.8 -3.17% -3.19% 970K
|
Health Technology
|
| O: 0.69%
H: 0.98%
C: -0.15%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.25%
H: 0.47%
C: -1.08%
JAZZ | $109.27 2.03% 2.01% 560K
|
Health Technology
|
| O: 1.08%
H: 1.22%
C: 0.92%
therapeutics growth market
Q BioMed Inc. Provides Update to Shareholders
Published: 2023-06-23 (Crawled : 12:00) - prnewswire.com
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 3833.33%
H: 0.0%
C: -94.07%
update
Q BioMed Inc. Provides Update to Shareholders - June 23, 2023
Published: 2023-06-23 (Crawled : 13:00) - biospace.com/
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 3833.33%
H: 0.0%
C: -94.07%
update
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe
Published: 2023-04-14 (Crawled : 13:20) - biospace.com/
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 1.35%
H: 19.33%
C: 2.67%
europe patent
Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio
Published: 2023-04-12 (Crawled : 04:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 5.41%
H: 0.0%
C: -2.14%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.57%
C: 3.57%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.75%
H: 0.5%
C: -0.05%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.96%
H: 0.71%
C: 0.22%
liver cancer growing market
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office
Published: 2023-02-10 (Crawled : 13:20) - prnewswire.com
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 24.0%
H: 191.94%
C: 132.26%
patent
Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-09 (Crawled : 03:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 6.07%
H: 1.75%
C: 0.35%
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -4.0%
H: 4.17%
C: 4.17%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.87%
H: 0.17%
C: -1.53%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 6.13%
H: 0.42%
C: -1.3%
liver cancer market
Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.
Published: 2022-11-14 (Crawled : 16:00) - prnewswire.com
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 11.18%
H: 8.47%
C: -1.59%
research
Q BIOMED PROVIDES SHAREHOLDER UPDATE
Published: 2022-10-11 (Crawled : 13:20) - biospace.com/
QBIO | $0.0002 100.0% 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 3.33%
H: 12.9%
C: 6.45%
update
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Last 48 Hours Insiders Buying
ADMQ | $0.0532 -4.14% -40.18% 480K
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 18K
|
Consumer Non-Durables
|
20:10